Associate Director, CMC Drug Substance

Your work will change lives. Including your own.

The Impact You’ll Make

Recursion is on the cutting edge of drug discovery, generating proprietary maps of biology that provide unique insights, driving target identification, validation, and ultimately novel clinical candidates. We are seeking an Associate Director, CMC Drug Substance to advance our current and future clinical assets through development and ultimately to patients in need.

In this role, you will:

• Lead external drug substance development across our portfolio including oversight of CDMOs and strategic technical development relationships
• Provide technical leadership, project management and oversight of drug substance process development and manufacturing activities supporting Recursion’s clinical programs
• Ensure delivery of drug substance from external manufacturing campaigns adhering to current quality guidelines and delivery timelines. Typical travel to external manufacturing sites is 10-20% of the time.
• Critically analyze process and analytical data to identify and resolve key synthetic challenges during drug substance development
• Participate in developing and extending our CDMO relationships, budget planning and forecasting for drug substance expenditures and achieving our quality requirements

As Associate Director, CMC Drug Substance, you will be an essential member of the Recursion CMC Team reporting to the Executive Director, CMC Drug Substance. The CMC Team is an empowered, execution‑minded group of scientists and technical experts responsible for translating Recursion’s innovative science to patients in clinic through CMC activities and deliverables.

• Ph.D. in organic chemistry or closely related field with a minimum of 5‑8 years experience or M.S. with 8‑12 years of experience
• Strong knowledge and experience in small molecule drug substance process development and manufacturing best practices across all phases of drug development, from initial regulatory filings through registration, validation and launch
• Prior experience leading external development and CDMO relationships is a plus
• Demonstration of cross‑functional understanding related to drug substance development including salt/polymorph screening, phase‑appropriate analytical development, standard process of drug product development, quality and regulatory affairs
• Well‑versed in the latest trends impacting drug substance technology, manufacturing and the outsourcing industry

This is an office‑based, hybrid position at our US headquarters located in Salt Lake City, Utah
. Employees are expected to work in the office at least 50% of the time.

At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is $163,800 to $192,400 (USD). You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.

• We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
• We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
• We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
• We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day.
• We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
• We are One Recursion. True cross‑functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Recursion (NASDAQ: RXRX) is a clinical‑stage Tech Bio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion…